11 – 20 of 137
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Incidence and risk factors for postoperative vaginal events following radical cystectomy for bladder cancer : a nationwide population-based study
- Contribution to journal › Article
- 2024
-
Mark
Similar immune responses to alpha1-oleate and Bacillus Calmette–Guérin treatment in patients with bladder cancer
- Contribution to journal › Article
-
Mark
Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
- Contribution to journal › Scientific review
-
Mark
Diagnostic value of repeated comprehensive investigation with CT urography and cystoscopy for recurrent macroscopic haematuria
- Contribution to journal › Article
-
Mark
Sex bias in FGFR3 somatic mutations in bladder cancer
- Contribution to journal › Article
-
Mark
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes
- Contribution to journal › Article
-
Mark
International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer - Principles of Classification and Emerging Clinical Utility
- Contribution to journal › Article
- 2023
-
Mark
The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients : a systematic review
- Contribution to journal › Scientific review
-
Mark
Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations : The EAU-RF NIMBUS Trial
- Contribution to journal › Article
